News
How a team of AIs discovered a promising lung-cancer drug
Researchers developed a ‘virtual biotech’ made up of as many as 37,000 agents reporting to an 'chief scientist'.
After examining the results of thousands of clinical trials, a swarm of AI agents suggested that a protein that dampens immune responses could be the target for a promising treatment for lung cancer.…
[Read Full Story on Nature.com →](https://www.nature.com/articles/d41586-026-02954-y)